loading

Relay Therapeutics Inc Azioni (RLAY) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
91.18%
0.677
7.679 - - -
Operating Expenses
16.23%
77.52
92.55 84.98 96.37 100.76
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
16.23%
77.52
92.55 84.98 96.37 100.76
Operating Income/Loss
9.45%
-76.85
-84.87 -84.98 -96.37 -100.76
Income/Loss From Continuing Operations Before Tax
100.88%
0.677
-77.06 - -88.11 -92.21
Income/Loss From Continuing Operations After Tax
8.68%
-70.38
-77.06 -76.00 -88.11 -92.21
Net Income/Loss
8.68%
-70.38
-77.06 -76.00 -88.11 -92.21
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.20%
171.26
169.23 8.2161 140.23 132.82
Basic Earnings Per Share
10.87%
-0.41
-0.46 -0.42 -0.63 -0.69
Diluted Earnings Per Share
10.87%
-0.41
-0.46 -0.42 -0.63 -0.69
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):